RT Journal
A1 Goldenberg AJ, Sharp RR
T1 THe ethical hazards and programmatic challenges of genomic newborn screening
JF JAMA
JO JAMA
YR 2012
FD February 1
VO 307
IS 5
SP 461
OP 462
DO 10.1001/jama.2012.68
UL http://dx.doi.org/10.1001/jama.2012.68
AB 
Advances in next-generation sequencing technologies have the potential to spur better integration of genetic testing into patient care. Appropriate utilization of these technologies will require the capacity to manage, interpret, and communicate large amounts of personal genetic information.1 Because the clinical infrastructure necessary to support these activities is currently limited,2 it is likely that the earliest applications of whole-genome sequencing will be restricted to settings in which genetic testing is already a routine part of clinical or public health practice, such as state newborn screening (NBS) programs.